147 related articles for article (PubMed ID: 15806138)
1. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Lab Invest; 2005 Jun; 85(6):768-79. PubMed ID: 15806138
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
[TBL] [Abstract][Full Text] [Related]
4. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682
[TBL] [Abstract][Full Text] [Related]
5. Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.
Saegusa M; Hashimura M; Kuwata T
Lab Invest; 2012 Apr; 92(4):511-21. PubMed ID: 22231735
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
[TBL] [Abstract][Full Text] [Related]
7. Regulation of beta -catenin transformation by the p300 transcriptional coactivator.
Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151
[TBL] [Abstract][Full Text] [Related]
8. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.
Saegusa M; Okayasu I
J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142
[TBL] [Abstract][Full Text] [Related]
9. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
10. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction.
Lévy L; Wei Y; Labalette C; Wu Y; Renard CA; Buendia MA; Neuveut C
Mol Cell Biol; 2004 Apr; 24(8):3404-14. PubMed ID: 15060161
[TBL] [Abstract][Full Text] [Related]
12. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.
Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA
Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022
[TBL] [Abstract][Full Text] [Related]
13. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4.
Hecht A; Stemmler MP
J Biol Chem; 2003 Feb; 278(6):3776-85. PubMed ID: 12446687
[TBL] [Abstract][Full Text] [Related]
14. The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway.
Ghiselli G; Coffee N; Munnery CE; Koratkar R; Siracusa LD
J Biol Chem; 2003 May; 278(22):20259-67. PubMed ID: 12651860
[TBL] [Abstract][Full Text] [Related]
15. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
Tutter AV; Fryer CJ; Jones KA
Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
[TBL] [Abstract][Full Text] [Related]
16. p73beta, a variant of p73, enhances Wnt/beta-catenin signaling in Saos-2 cells.
Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K
Biochem Biophys Res Commun; 2001 May; 283(2):327-33. PubMed ID: 11327702
[TBL] [Abstract][Full Text] [Related]
17. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
[TBL] [Abstract][Full Text] [Related]
18. Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T
J Pathol; 2010 Dec; 222(4):410-20. PubMed ID: 20922712
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
20. A functional role of Cdx2 in beta-catenin signaling during transdifferentiation in endometrial carcinomas.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Wani Y; Okayasu I
Carcinogenesis; 2007 Sep; 28(9):1885-92. PubMed ID: 17468517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
